1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
AK Medical Holdings Ltd.

AK Medical Holdings Ltd.

HHKEX:1789
4.29
HKD
-0.14
(-3.27%)
6.38BMarket Cap
Mar 31Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.15
0.21
0.27
0.49
0.58
0.89
0.94
0.68
0.95
0.98
1.21
1.33
- -
Basic EPS, GAAP
0.05
0.06
0.08
0.14
0.14
0.26
0.28
0.08
0.18
0.16
0.25
0.3
- -
Free Cash Flow per Basic Share
0.04
0.01
0.04
0.09
0.05
0.04
0.1
0.09
0.11
-0.15
0.26
0.24
- -
Dividend per Share
0.03
0.1
0.05
0.1
0.03
0.03
0.07
0.03
0.02
0.06
0.04
0.07
- -
Book Value per Share
0.16
0.18
0.29
0.67
0.81
1.06
1.83
1.82
2.01
2.13
2.36
2.6
2.6
Tangible Book Value per Share
0.15
0.17
0.29
0.66
0.75
0.98
1.63
1.61
1.77
1.89
2.13
2.38
2.38
Basic Weighted Avg Shares
1,000
1,000
1,000
758
1,037
1,042
1,102
1,113
1,109
1,113
1,116
1,117
1,117
Sales/Revenue/Turnover
148
206
271
373
601
927
1,035
761
1,052
1,094
1,346
1,482
- -
Operating Margin (%)
38.97
35.39
34.48
33.51
28.51
32.66
36.49
13.06
22.66
19.33
22.34
25.22
- -
Depreciation Expense
5
5
9
12
21
32
61
74
80
91
96
107
- -
Net Income, GAAP
52
65
77
105
145
267
314
93
205
182
274
339
- -
Effective Tax Rate (%)
14.22
14.54
18.63
15.96
16.94
16.93
16.62
14.68
14.78
21.21
14.35
14.15
- -
Profit Margin (%)
34.88
31.48
28.56
28.27
24.13
28.81
30.33
12.16
19.46
16.65
20.35
22.87
- -
Working Capital
126
123
223
552
597
790
1,485
1,445
1,629
1,477
1,582
2,042
2,042
LT Debt
- -
- -
- -
- -
- -
6
15
31
25
49
27
9
9
Total Equity
156
177
294
668
842
1,116
2,043
2,032
2,244
2,392
2,638
2,913
2,913
Return on Invested Capital (%)
- -
36.77
30.81
20.88
18.17
25.49
18.56
3.98
8.46
7.01
9.99
11.36
- -
Return on Capital (%)
- -
39
32.81
21.9
19.19
27.15
19.71
4.54
9.49
7.7
10.54
11.91
- -
Return on Common Equity (%)
- -
39
32.81
21.9
19.2
27.28
19.88
4.55
9.58
7.86
10.89
12.22
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
73
142
77
LT Borrowings
18
6
5
LT Finance Leases
9
6
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,116
1,116
1,119
Market Capitalization
5,087
6,103
5,729

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
2,178
2,582
2,700
Cash, Cash Equivalents & STI
1,024
1,441
1,244
Accounts Receivable, Net
495
521
628
Inventories
489
460
459
Total Current Liabilities
596
737
658
Payables & Accruals
- -
- -
- -
ST Debt
73
142
77
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
37.21%
7.44%
10.41%
Free Cash Flow
13.31%
-102.07%
-5.92%
Net Income, GAAP
30.85%
22.75%
23.79%
Sales/Revenue/Turnover
24.5%
9.77%
10.11%
Total Cash Common Dividend
18.1%
21.07%
59.71%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,094
2024
- -
- -
1,346
2025
- -
- -
1,482

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.16
2024
- -
- -
0.25
2025
- -
- -
0.3

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.06
2024
- -
- -
0.04
2025
- -
- -
0.07

Company Description

Company Profile APIChatGPT
CEO
Zhi Jiang Li
Full Time Employees
983
Sector
Health technology
Industry
Medical specialties
Address
AK Medical Industrial Park Beijing BE China 102299
IPO Date
Dec 20, 2017
Website
ak-medical.net
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
AK Medical Holdings Limited functions as an investment holding company, driving the design, development, manufacturing, and global commercialization of orthopedic joint implants and associated medical products. The company features a robust portfolio of offerings, including hip, knee, spine, and trauma replacement implants. A significant area of innovation lies in its advanced 3D-printed products, which encompass bespoke hip and knee implants, artificial vertebral bodies, and spinal interbody cages. Furthermore, AK Medical distributes a range of third-party orthopedic solutions and produces essential surgical instruments and medical irrigators. Recognized as a pioneer in the orthopedic sector, the company was the first globally to apply additive manufacturing (3D printing) technology to joint replacement, spine care, and trauma implants. Its solutions are supplied to a broad base of distributors, hospitals, medical professionals, and patients across China and international markets, supported by manufacturing facilities in both China and the United Kingdom. AK Medical, established in Beijing, People's Republic of China, in 2003, continues to expand its footprint and influence in the global healthcare industry.